$ACAD
ACADIA PHARMACEUTICALS INC Stock $acad

2011 Q2 Form 10-Q Financial Statement

Concept	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$40.40M
YoY Change	17.78%
Cash & Equivalents	$8.020M
Short-Term Investments	$32.30M
Other Short-Term Assets	$700.0K
YoY Change	-36.36%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$41.00M
YoY Change	7.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$200.0K
YoY Change	-71.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$100.0K
YoY Change	-50.0%
Total Long-Term Assets	$300.0K
YoY Change	-66.67%
TOTAL ASSETS
Total Short-Term Assets	$41.00M
Total Long-Term Assets	$300.0K
Total Assets	$41.30M
YoY Change	5.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.100M
YoY Change	-52.17%
Accrued Expenses	$4.000M
YoY Change	-2.44%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$0.00
YoY Change	-100.0%
Total Short-Term Liabilities	$5.900M
YoY Change	-54.62%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change	-100.0%
Other Long-Term Liabilities	$2.500M
YoY Change	-89.13%
Total Long-Term Liabilities	$2.500M
YoY Change	-89.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.900M
Total Long-Term Liabilities	$2.500M
Total Liabilities	$8.500M
YoY Change	-76.39%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$32.82M
YoY Change
Total Liabilities & Shareholders Equity	$41.30M
YoY Change	5.36%

Concept	2011 Q2
OPERATING ACTIVITIES
Net Income	-$6.556M
YoY Change	52.47%
Depreciation, Depletion And Amortization	$40.00K
YoY Change	-71.43%
Cash From Operating Activities	-$5.280M
YoY Change	-16.72%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$6.430M
YoY Change	-332.97%
Cash From Investing Activities	$6.430M
YoY Change	-332.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	50.00K
YoY Change	-145.45%
NET CHANGE
Cash From Operating Activities	-5.280M
Cash From Investing Activities	6.430M
Cash From Financing Activities	50.00K
Net Change In Cash	1.200M
YoY Change	-113.03%
FREE CASH FLOW
Cash From Operating Activities	-$5.280M
Capital Expenditures
Free Cash Flow
YoY Change

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q2	us-gaap	Stockholders Equity StockholdersEquity	32821000